• 首頁
  • 投資者關系
  • 信息披露
  • 可持續發展
  • 廣藥動态
  • English
财務指标股本狀況流通股東 治理結構 股東回報情況公平在身邊投資者保護宣傳
定期報告臨時公告
可持續發展治理穩健:透明合規 行穩緻遠品質保障:匠心守護 健康可及價值創新:科技驅動 數智未來綠色發展:低碳循環 和諧共生合作共赢:共建生态 韌性發展可持續發展報告我們的故事
About UsFinancial HighlightsShare CapitalShareholdersDistribution PlanRegular ReportSustainabilityCSR & ESG Report
  • About Us
  • Financial Highlights
  • Share Capital
  • Shareholders
  • Distribution Plan
  • Regular Report
  • Sustainability
  • CSR & ESG Report

SUMMARY OF THE 2025 ANNUAL REPORT

2026-03-23 15:34:05

SUMMARY OF THE 2025 INTERIM REPORT

2025-08-16 14:12:40

2025 FIRST QUARTERLY REPORT

2025-04-30 10:28:57

Annual Report 2024

2025-04-11 16:36:42

SUMMARY OF THE 2024 ANNUAL REPORT

2025-03-14 11:05:57

SUMMARY OF THE 2024 INTERIM REPORT

2024-09-02 14:46:39

Annual Report 2023

2024-04-19 08:56:22

SUMMARY OF THE 2023 ANNUAL REPORT

2024-03-16 11:44:20

2023 THIRD QUARTERLY REPORT

2023-10-31 16:49:58

Interim Report 2023

2023-09-12 09:10:29

SUMMARY OF THE 2023 INTERIM REPORT

2023-08-19 09:23:30

Annual Report 2022

2023-04-14 09:25:33

SUMMARY OF THE 2022 ANNUAL REPORT

2023-03-18 14:56:23

2022 THIRD QUARTERLY REPORT

2022-10-26 01:11:24

Interim Report 2022

2022-09-14 01:10:18

關於我們    |    聯系我們

電(diàn)話:(8620)66281011    傳(chuán)真:(8620)66281229    地址:廣州市荔灣區沙面北街45号

廣州白雲山醫藥集團股份有限公司 版權所有 Copyright © 2000-2020 gybys.com.cn, All Rights Reserved 粵ICP備13064121号